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Abstract
Ferritin-like molecules are unique to cellular iron homeostasis because they can store iron at
concentrations much higher than those dictated by the solubility of Fe3+. Very little is known
about the protein interactions that deliver iron for storage, or promote the mobilization of stored
iron from ferritin-like molecules. Here, we report the X-ray crystal structure of Pseudomonas
aeruginosa bacterioferritin (Pa-BfrB) in complex with bacterioferritin-associated ferredoxin (Pa-
Bfd) at 2.0 Å resolution. As the first example of a ferritin-like molecule in complex with a cognate
partner, the structure provides unprecedented insight into the complementary interface that enables
the [2Fe-2S] cluster of Pa-Bfd to promote heme-mediated electron transfer through the BfrB
protein dielectric (~18 Å), a process that is necessary to reduce the core ferric mineral and
facilitate mobilization of Fe2+. The Pa-BfrB-Bfd complex also revealed the first structure of a Bfd,
thus providing a first view to what appears to be a versatile metal binding domain ubiquitous to
the large Fer2_BFD family of proteins and enzymes with diverse functions. Residues at the Pa-
BfrB-Bfd interface are highly conserved in Bfr and Bfd sequences from a number of pathogenic
bacteria, suggesting that the specific recognition between Pa-BfrB and Pa-Bfd is of widespread
significance to the understanding of bacterial iron homeostasis.
INTRODUCTION
Iron is an essential nutrient needed as cofactor in respiration, nitrogen fixation,
photosynthesis, and DNA synthesis and repair.1,2 Iron acquisition, storage and utilization are
subject to tight homeostatic regulation because the soluble Fe2+ can react with O2 to form
reactive oxygen species and the highly insoluble Fe3+.3 The challenges presented to cells by
the chemical properties of iron have been largely answered in the unique structure and
function of ferritin and ferritin-like molecules. These have nearly spherical and hollow
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structures assembled from 24 subunits (~ 450 kDa) where each subunit consists of a four-
helix bundle and a short C-terminal helix that is nearly perpendicular to the bundle. The
pivotal contributions made by ferritin-like molecules to iron homeostasis are manifested by
their presence in all three domains of life with remarkable conservation of structure and
function despite very low conservation in sequence (<20%).4,5 Three types of ferritin-like
molecules are present in bacteria: the ferritins (Ftn), the bacterioferritins (Bfr), and the Dps
(DNA binding proteins from starved cells).2 Ftns and Bfrs are composed of 24 subunits that
assemble into a spherical protein with a hollow cavity approximately 8 nm in diameter
where the iron mineral is stored. Dps are composed of 12 subunits, which assemble into a
nearly spherical protein with a central cavity approximately 4.5 nm diameter. A unique
property of the bacterioferritins, which only occur in bacteria and archaea,4 is that they bind
a heme molecule between two subunits (Figure 1a), so that the 24-mer protein consists of 12
subunit dimers and 12 hemes (Figure 1b). The heme is buried deep below the protein surface
(~13 Å) such that the heme propionates reach into the interior cavity where the iron mineral
is stored (Figure 1c).
Ferritin and ferritin-like molecules capture Fe2+, convert it to Fe3+ at catalytic centers
located in the middle of each subunit, using O2 or H2O2 as oxidants, and store Fe3+ as a
mineral in their hollow cavities, effectively concentrating Fe3+ to levels orders of magnitude
higher that those permitted by its low solubility.6 When the nutrient is needed in
metabolism, the ferric mineral is solubilized by reducing it to Fe2+, which exits the protein
shell via channels formed in the 24-mer assembly.5,7-9 The biological ligands or the protein-
protein interactions that enable electron transfer into the interior cavity of eukaryotic ferritin
to promote release of Fe2+ have thus far remained mysterious. Studies of E. coli and P.
aeruginosa Bfr suggest that recovery of iron from the Bfr cavity requires specific protein-
protein interactions to mediate electrons into the Bfr core and promote Fe2+ release.10-12
Although the heme in Bfr is thought to mediate electrons across the ~20 Å protein
shell,10,13,14 the fact that it is buried deep below the surface (Figure 1c) has made it
challenging to understand how cognate partners may interact with Bfr and how the electrons
supplied via protein-protein interactions reach the heme. Nevertheless, attaining atomic level
understanding of the intermolecular interactions that enable ferritin-like molecules to
maintain iron homeostasis in bacteria is important because of the recent demonstration that
bacterial iron storage proteins are critical for the survival of pathogens in the host and
therefore may be attractive targets for antimicrobial development.15
P. aeruginosa is a Gram negative opportunistic pathogen, and is the major pathogen
responsible for the decline of lung function and premature death in patients with cystic
fibrosis by virtue of persistent infections that steadily destroy host tissues.16,17 In P.
aeruginosa and in E. coli the bfr gene is contiguous to a gene dubbed bfd (bacterioferritin-
associated ferredoxin) for its proximity to bfr and the fact that its product binds a [2Fe-2S]
cluster.11,12,18,19 E. coli Bfd (Ec-Bfd) binds to Ec-Bfr, which led several groups to suggest
that Ec-Bfd may function either as electron acceptor in the process of iron uptake by Ec-Bfr
or as electron donor in iron mobilization from Ec-Bfr.11,12 This issue has been pursued in
more detail in P. aeruginosa,10 capitalizing on its known global genetic response to high- or
low-iron concentrations.20,21 Among the large number of genes responding to low-iron
stimulus, bfd is strongly up-regulated, and a gene coding a ferredoxin reductase (fpr) is also
up-regulated, whereas bfrB is down-regulated. The strong up-regulation of bfd under low-
iron prompted us to suggest that Pa-Bfd may participate in the mobilization of iron from Pa-
BfrB by mediating electrons from Pa-FPR to Pa-BfrB, enabling reduction of the ferric
mineral and the release of Fe2+.10 Characterization of the proteins coded by the bfd, fpr and
bfr genes in P. aeruginosa showed that Pa-FPR is a 29.4 kDa, NADPH-dependent
flavoprotein19,22 and Pa-Bfd is a 7.1 kDa protein that binds a [2Fe-2S] cluster.19 An early
investigation suggested that Pa-Bfr is a heteropolymer assembled from two different
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subunits, α-Bfr and β-Bfr.23 Subsequent studies established the presence of two genes
encoding ferritin-like molecules (bfrA and bfrB) but suggested that two distinct
bacterioferritins (Pa-BfrA and Pa-BfrB) may coexist.24 More recently, we showed that the
product of bfrB is a genuine bacterioferritin assembled from 24 identical subunits and 12
heme molecules,25 whereas the product of bfrA, also assembled from 24 identical subunits,
does not bind heme and is not a bacterioferritin but a bacterial ferritin, now termed Pa-
FtnA.26 Hence, two distinct ferritins coexist in P. aeruginosa, a bacterioferritin (Pa-BfrB)
and a bacterial ferritin (Pa-FtnA).
In vitro reconstitution of Pa-BfrB with Pa-FPR, Pa-Bfd and NADPH enables heme-mediated
electron transfer into the Pa-BfrB cavity and release of Fe2+. In the absence of Pa-Bfd the
heme is not reduced and iron is not mobilized from Pa-BfrB,10 indicating that Pa-Bfd
mediates electrons between Pa-FPR and Pa-BfrB. Similar experiments conducted with apo-
Pa-Bfd prepared in situ, however, showed that apo-Pa-Bfd also stimulates the rapid
mobilization of Fe2+ from Pa-BfrB, suggesting the possibility that the role of apo-Bfd is to
recruit the reductase (Pa-FPR) to the Pa-BfrB surface.10 Thus, although the interplay
between BfrB, Bfd and FPR is a unique example of specific protein interactions regulating
the function of ferritin-like molecules, the particular roles played by Bfd and FPR in the
release of iron remain unclear. Herein we report the crystal structure of the Pa-BfrB-Pa-Bfd
complex, which reveals a highly complementary interface that positions the [2Fe-2S] cluster
of Pa-Bfd in an ideal position to transfer electrons to the heme in Pa-BfrB. The structure also
provides a first insight into the Bfd fold, which appears to require a phosphate ion for
optimum stability, a finding that was exploited to prepare apo-Pa-Bfd and demonstrate that
the [2Fe-2S] cluster must be present in Pa-Bfd to support heme reduction and Fe2+
mobilization from Pa-BfrB.
EXPERIMENTAL PROCEDURES
Pa-BfrB and the C34S mutant of Pa-Bfd were prepared and purified as reported
previously.10 The C43S mutant is more stable to purification storage and manipulation but
has the same spectroscopic and functional properties of Pa-Bfd.10 Hence, in this report the
C34S mutant will be referred to as Pa-Bfd. The preparation of Pa-BfrB containing ~600 iron
atoms per Pa-BfrB molecule and the experiments conducted to measure iron release from
Pa-BfrB were carried out as described previously.10
Preparation of Apo-Bfd
A 0.8 mM solution of Pa-Bfd in 50 mM potassium phosphate (pH 7.0), 150 mM NaCl, 5
mM DTT was diluted 8 times in buffer 1, consisting of sodium acetate buffer (150 mM, pH
5.5) 8 M urea, 150 mM NaCl, 5 mM tris(2-carboxyethyl)phosphine (TCEP) and 3 mM
hydroxybenzyl ethylenediamine (HBED). The resultant solution was stirred continuously at
room temperature for 70 min. Iron chelated by HBED was removed by dialysis against
buffer 1 at room temperature. HBED was then removed by dialysis against buffer 1 without
the chelator and the apo-protein was then dialyzed against buffer 2 (200 mM potassium
phosphate, 8 M urea, 5 mM TCEP, pH 7.0) at room temperature. Refolding of apo-Bfd was
carried out in two steps by dialyzing the protein against buffer 2 containing 4 M urea at 4
°C, and then against buffer 2 without urea at 4 °C.
Crystallization and X-ray data collection
Crystal growth conditions were screened with solutions of Pa-BfrB (40 μM) in 100 mM
potassium phosphate (pH 7.6), 1 mM TCEP, and Pa-Bfd (480 μM) in 50 mM potassium
phosphate (pH 7.0), 150 mM NaCl and 5 mM DTT. The solutions were combined to
produce a mixture with a 12Bfd:1BfrB mole ratio. Equal volumes of protein and crystallant
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(1 μL) were equilibrated against 100 μL of the latter in sitting drop vapor diffusion plates at
18 °C. Small prismatic crystals were obtained in 1-2 days with condition G8 (0.8 M Na/K
hydrogen phosphate, pH 7.5) of the Proplex HT screen (Molecular Dimensions). Crystals
were transferred to a fresh drop of 80% crystallization solution and 20% glycerol before
flash freezing. Data were collected (λ=1.0000 Å) at the Advanced Photon Source beamline
17ID, Argonne National Laboratories, using a Dectris Pilatus 6M pixel array detector.
Structure solution and refinement
Intensities were integrated using XDS27 and the Laue class check and data scaling were
performed with Aimless.28 The highest probability Laue class was 4/mmm and space group
P4212. The Matthew’s coefficient (Vm)29 and % solvent content were estimated to be 2.9
and 58.2% for 6 Pa-BfrB subunits in the asymmetric unit. Structure solution was conducted
by molecular replacement with Phaser30 via the Phenix31 interface. All space groups with
422 point symmetry were tested using a Pa-BfrB dimer from a previously determined
structure (PDB: 3IS7)25 as the search model. The top solution, consisting of three subunit-
dimers, was obtained in the space group P4212, which was used from this point forward.
Following initial refinement with Phenix, difference electron density (Fo-Fc) consistent with
Bfd molecules near the heme at the interface of each BfrB subunit-dimer were manually fit
to the model using Coot32 and the structure was refined with Phenix. A second data set was
collected with the same crystal at the Fe-edge (λ = 1.73769 Å) and anomalous difference
electron density maps were calculated to confirm the orientation of the Fe-S cluster in the
Bfd molecules. Structure validation was conducted with Molprobity33 and the data
collection and refinement statistics are in Table 1. There were no amino acid outliers in the
Ramachandran plot where 99.3% and 0.7% resided in the favored and allowed regions
respectively.
RESULTS AND DISCUSSION
Overall Structure of the Pa-BfrB-Bfd Complex
The crystal structure of Pa-BfrB in complex with Pa-Bfd (Pa-BfrB-Bfd) was determined at
2.0 Å resolution. The asymmetric unit cell contains three BfrB subunit dimers, each
associated with electron density consistent with a Bfd molecule (Figure 2a). Well-defined
electron density describes a molecule of Bfd bound at the interface of each BfrB subunit
dimer in the asymmetric cell unit, above each of the heme molecules (Figure 2b and 2c).
Hence, the biological assembly consists of a nearly spherical 24-mer BfrB with 12 heme and
12 Bfd molecules (Figure 2d). As observed in previous structures of Pa BfrB,25 electron
density greater than 3σ is observed in the four-fold pores, which was modeled as potassium
ions (purple) based on distances and coordination geometry. In addition, when sodium ions
were refined at these sites, positive electron density was observed, which suggest that
assignment as potassium is most likely correct. Barium and iron ions have also been
observed in four-fold pores of Azotobacter vinelandii Bfr, leading to the suggestion that iron
ions may traffic in and out of bacterioferritin via four-fold pores.34,35 In addition, and
previously not observed in other bacterioferritin structures, positive electron density greater
than 3σ is present at the B-pores of Pa BfrB in the BfrB-Bfd complex. This electron density
was successfully modeled as sodium ions (green) coordinated by D34 from one of the
subunits forming a B-pore and by D132 and T136 from another subunit related by
crystallographic symmetry. Refinement as potassium ions or water molecules resulted in
negative and positive electron density at these sites, respectively, which suggests that
sodium ions are the most probable choice. Fo-Fc omit maps of electron density present in the
four-fold and B-pores are shown in Figures 2e and 2f, respectively. The presence of sodium
ions in B pores is the first structural evidence supporting the idea that B-pores in Bfr may
serve as conduits for ion traffic.36 The ferroxidase center in the structure of the Pa-BfrB-Bfd
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complex is devoid of iron (magenta in Figure 2g) and the ferroxidase ligands adopt
conformations identical to those observed in the empty ferroxidase center of Pa-BfrB
alone25 (green in Figure 2g).
The bfd fold
The structure of Pa-Bfd, revealed as part of the structural determination of the Pa-BfrB-Bfd
complex, is the first structure of a Bfd molecule. The fold, comprised of helix-turn-helix,
binds a [2Fe-2S] center via C-4, C-6, C-38 and C-41, located in loops 1 and 3 (Figure 3a),
which are oriented nearly anti-parallel to one another and supported by three α-helices.
Loop 1 (L1) contains C-4 and C-6 and is followed by a 3-turn helix (α-1). Loop 2 (L2)
connects α-1 to the shortest helix in the structure, the two-turn α-2, which is followed by
loop 3 (L3) containing C-38 and C-41. The longest helix in the structure (α-3) spans from
C-41 to Q-57, which is the last residue for which electron density is observed. Anomalous
difference electron density maps obtained from data collected at the Fe-edge allowed
unambiguous identification of the iron atoms and placement of the [2Fe-2S] cluster (Figure
3b). The average Fe-Fe distance is 2.85 Å and the average Fe-S(Cys) and Fe-S2− distances
are 2.31 Å and 2.22 Å, respectively, which are similar to those observed in structures of
[2Fe-2S]-containing proteins.
Bfd-like sequences are present in a number of bacteria (Supplementary Figure S1). Four
conserved cysteine residues are organized in a unique C-X1-C-X31-32-C-X2-C- arrangement
in a peptide that at 73 residues long is ~50 residues shorter than [2Fe-2S] ferredoxins from
bacteria, plants, fungi and vertebrates. Hence, Bfd is a class of [2Fe-2S] ferredoxin
distinguishable from the others by its sequence and spectroscopic properties.12 Search of the
Pfam database37 shows that the Bfd sequence determines a large, manually curated Pfam
family, Fer2_BFD (PF04324), of single and multiple domain proteins where the C-X1-C
arrangement is highly conserved and the C-X2-C arrangement is partially conserved. The
Fer2_BFD sequence is present in multidomain enzymes and proteins with a variety of
functions, such as nitrate, nitrite and sulfite reductases, FAD-dependent oxidoreductases,
nitrogen fixation (NifU) proteins and copper and mercury transport proteins. Structural
alignment searches conducted with I-COFACTOR,38 DALI39 and PdBeFold40 strongly
suggest that the Bfd fold has not been previously observed in a single domain protein. It is
interesting, however, that close matches were observed to a portion of the α-subunit of
heterotetrameric sarcosine oxidase (TSOX) from Corynebacterium sp.,41 to a section of the
α-subunit of the heterooctameric proline dehydrogenase (PDH1) from Pirococcus
horikoshii,42 and to the N’terminal domain of the chaperone CopZ from Archaeoglobus
fulgidus.43
Figure 3c illustrates how an equivalent of the Bfd fold (cyan) is contained within a relatively
small portion of the α-subunit of PDH1 (magenta); despite the strong structural conservation
there is no significant sequence similarity between the proteins. CopZ is a two-domain
protein member of the Fer2-BFD family that binds a Zn2+ and a [2Fe-2S] cluster in its N-
terminal domain. Its [2Fe-2S] cluster is bound by four Cys ligands arranged in a C-X1-C-
X31-C-X8-CC motif, which includes the conserved C-X1-C arrangement. Pa-Bfd and CopZ
share 60% sequence similarity in the stretch flanking the C-X1-C motif (V2-A17 in Bfd;
V74-A88 in CopZ-NT). In CopZ-NT, this stretch of sequence forms a β-hairpin that
contains iron ligands C75 and C77, which are structurally equivalent to C4 and C6 in Pa-
Bfd, and a subsequent α-helix (magenta in Figure 3d). C109 is on a one-turn α-helix (green)
in CopZ-NT and therefore is structurally distinct from C38 in Pa-Bfd, which is part of L3.
C119, on the other hand, is structurally equivalent to C41 in Pa-Bfd. Consequently, to the
best of our knowledge the structure of Pa-Bfd is the first example of a single domain
Fer2_BFD protein, and the structure of CopZ-NT appears to be the only example of a multi-
domain Fer2_BFD protein, although the structure describes only the 130-residue N’-
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terminal domain. Taken together, the observations made from sequence and structural
alignments indicate that the Bfd fold is a versatile metal-binding structural motif that has
been incorporated into a large number of Fer2_BFD proteins and enzymes with diverse
function, as well as into enzymes not belonging to this family, such as TSOX and PDH1.
Phosphate stabilizes the Bfd structure
The three Bfd molecules in the asymmetric unit cell, chains G, H and I, exhibit average main
chain B-factors 25.8, 64.0 and 29.0 Å2, respectively (Figure 4a). Despite the higher thermal
factors and absence of electron density between residues 16 and 33 in chain H (green), the
three Bfd chains are structurally similar as is evident from the small Cα RMSD from
comparing chain G to chain I (0.24 Å) and to chain H (0.25 Å) (Figure S2). Strong positive
Fo – Fc electron density greater than 6σ near chain G was modeled as a phosphate ion
coordinated by the side chains of R26, R29 and K46 and, via a crystal contact, by the side
chain of K76 from a nearby BfrB (Figure 4b). The shape of the observed electron density
along with the fact that phosphate was present in the protein storage buffer and
crystallization solution made assignment of phosphate at this site unambiguous. Phosphate
likely mediates otherwise repulsive interactions of the R26 (α-2), R29 (α-2) and K46 (α-3)
side chains and enables their hydrophobic portions to pack against the Y25 (α-2) side chain
and form a network that stabilizes the short α-2 helix. The phosphate-mediated stabilization
of α-2 may be critical to the integrity of the Bfd fold and that of the [2Fe-2S] cluster
because in its absence α-2 is likely to unfold and create a long loop stretching from the N-
terminus of L2 (Ala15) to the C-terminus of L3 (Ala41) (see Figure 3a). The proposed
stabilizing role of phosphate is in agreement with three experimental observations: (i)
isolation of recombinant Pa-Bfd can only be carried out in phosphate buffer, (ii) attempts to
transfer Pa-Bfd into non-phosphate buffers causes gradual loss of the [2Fe-2S] cluster, and
(iii) crystals of the Pa-BfrB-Bfd complex can only be obtained if each of the proteins is
dissolved in phosphate buffer and if the precipitant contains high phosphate concentrations.
Inspection of crystal contacts also supports this idea (Figure 4c): In Bfd chain G (magenta
spheres) and chain I (orange spheres) several crystal contacts affecting R26 and R29
contribute to organize α-2. In contrast, chain H (green spheres) does not experience crystal
contacts, which is likely the reason why residues 16-33, which comprise the C-terminal of
α-1, L2, α-2 and the N-terminus of L3, are disordered. It is therefore likely that the situation
observed in chain H most closely represents solution conditions, where a dynamic on-off
coordination of phosphate by R26, R29 and K46 prevents large unfolding excursions of α-2,
in turn maintaining the integrity of the [2Fe-2S] cluster.
To further explore this idea, the structural fluctuations in Pa-Bfd bound to phosphate were
compared with the fluctuations in the structure upon removal of phosphate in silico. A
coarse-grained normal mode analysis was performed for the phosphate-bound and
phosphate-free structures with the aid of the program Vibe,44 which treats protein structures
as an elastic network of the center of mass of each residue in the sequence. The calculations
suggest that residues C38 (iron ligand), G39 and K40 in loop L2 and G21 in loop L3 exhibit
fluctuations larger than other residues in the phosphate-bound structure (Fig. 4d). Note that
phosphate, shown at the end of the sequence in the plot, is one of the most kinetically active
moieties, which may be indicative of its propensity to be in dynamic on-off equilibrium with
Pa-Bfd. Removal of phosphate causes a relatively large increase in the fluctuations of Y25,
R26 and R29 in α-2, and A42 and K46 in α-3 (Fig. 4e), consistent with the proposed
stabilizing influence of the anion on α-2 (Figure 4-b).
The Pa-BfrB-Bfd interface
A molecule of Bfd binds between two BfrB subunits resulting in the burial of 607 Å2 at the
complex interface. The identities of residues participating at the interface and their relative
Yao et al. Page 6













contribution to the buried surface are shown in Figure 5; the contribution of Bfd residues to
the total buried surface is plotted in Figure 5a and the contribution of BfrB residues is
plotted in Figure 5-b, with residues from subunit A in gray and residues from subunit B in
wheat. The symbols on top of each bar indicate that a particular residue is conserved (*) or
conservatively replaced (:) in the amino acid sequence alignments shown in Figure S1. It is
significant that the majority of residues buried at the complex interface are conserved in the
sequences of both proteins because it strongly suggests that the structure of the complex is
biologically relevant, and underscores the notion that binding of Bfd to Bfr is a common
mechanism for the regulation of cytosolic iron in a variety of Gram negative bacteria.
A zoomed-in view of the interacting surface (Figure 5c) shows Pa-Bfd (cyan) bound at the
interface of two subunits in Pa-BfrB; subunit A is gray and subunit B is wheat. Y2, L5 and
K40, 3 of the 4 residues with the largest contributions to the buried Bfd surface, wedge their
side chains in a cleft formed at the interface of each subunit dimer in Pa-BfrB. In
comparison, M1, the fourth Pa-Bfd residue with the largest contribution to the buried
complex interface interacts only with subunit A via hydrophobic and hydrogen bond
contacts. The structure of each Pa-BfrB subunit dimer in complex with Pa-Bfd is very
similar to the subunit dimer structure of Pa-BfrB alone; the average RMSD from comparing
main chain and side chain atoms from Pa-BfrB subunits A and B in the Pa-BfrB-Bfd
complex with equivalent subunits in the structure of Pa-BfrB alone is 0.14 Å and 0.67 Å,
respectively (see Figure S3). The relatively small re-arrangements on the surface of Pa-BfrB
upon binding of Pa-Bfd are illustrated in Figure 6: The view in Figure 6a shows a cleft
formed at the interface of subunits A (wheat) and B (gray) in Pa-BfrB alone. Binding of Pa-
Bfd (cyan) occurs with the burial of the Y2 and L5 side chains within the cleft and is
accompanied by reorientation of the ,  and  side chains on Pa-BfrB, effectively
narrowing the cleft to contain the pertinent Pa-Bfd side chains (Figure 6b). These side chain
relocations and those affecting  are depicted in the view of Figure 6c to illustrate that
with the exception of , all the Pa-BfrB side chains that change orientation upon binding
form hydrogen bonding interactions with Pa-Bfd.
Each heme in Bfr is buried within a subunit dimer, placing the heme-iron ~ 18 Å below the
Bfr surface and allowing the heme propionates to reach the interior cavity. Although it has
been determined that the hemes in Bfr mediate electrons from the surface to the mineral
core,10,14 the vast and complex Bfr surface has made it challenging to identify electron
transfer paths connecting the surface and the buried heme. The structure of the BfrB-Bfd
complex reveals that the edge-to-edge distance between the [2Fe-2S] cluster in Bfd and
heme in BfrB is 15.1 Å. With the aid of the program Harlem45 the coordinates of the BfrB-
Bfd complex were used to calculate the most probable path for electron transfer, which is
likely to proceed from S2 in the iron sulfur cluster of Pa Bfd to a heme vinyl β carbon
(CBB) in Pa-BfrB, via conserved residues  and  (Figure 7a). A model with inside view
of Pa-BfrB (Figure 7b) illustrates how  and  in Pa-BfrB (purple) bridge the iron sulfur
cluster of Pa-Bfd located at the complex interface to the heme (green) buried deep within the
Pa-BfrB structure. The model also shows how the heme propionates protrude into the
interior cavity, suggesting that the iron mineral may be in intimate contact with the heme
propionates, thus facilitating electron capture and dissolution in the form of Fe2+.
Functional significance
In the complex, the [2Fe-2S] cluster of Pa-Bfd is in an ideal position to transfer electrons to
the heme in Pa-BfrB, an observation that strongly supports the notion that Pa-Bfd promotes
the release of Fe2+ from bacterioferritin by mediating electrons from Pa-FPR to Pa-BfrB.10
However, before the model can be firmly established it is necessary to consider that in the
Yao et al. Page 7













previous study efficient Fe2+ release was also observed when Pa-BfrB was reconstituted
with Pa-FPR and apo-Pa-Bfd.10 Since the latter is devoid of an iron sulfur cluster, it was
suggested that apo-Bfd may function to facilitate electron transfer from Pa-FPR to Pa-BfrB
perhaps by recruiting Pa-FPR to the Pa-BfrB surface.10 It is noteworthy, however, that in the
previous study apo-Bfd was prepared in-situ by incubating Pa-Bfd with dithionite and the
iron chelator 2,2′-bipyridine (bipy), so the resultant solution contained iron and sulfide ions.
Their presence could have caused spontaneous reassembly of a [2Fe-2S] cluster in apo-Bfd,
or redox reactions that facilitated iron release. Consequently, to understand the role, if any,
of apo-Bfd in aiding iron release from Pa-BfrB, it is necessary to prepare, isolate and
characterize the apo-protein for subsequent evaluation of its participation in iron release.
Apo-Bfd was prepared by incubating Pa-Bfd in 8 M urea in the presence of the iron chelator
HBED at pH 5.5. Chelated iron and sulfide were removed by dialysis while maintaining the
apo-protein in an unfolded state and the apo-Bfd was then refolded by dialysis against
phosphate buffer. Attempts to refold apo-Bfd by dialysis against a buffer other than
phosphate resulted in irreversible precipitation. The molecular mass of isolated apo-Bfd
(7,807 ± 1 Da) measured by mass spectrometry is identical to the value calculated from the
sequence, including the initiator Met. The UV-vis spectrum of apo-Bfd shows only a 280
nm band and is clearly distinct from the spectrum of Pa-Bfd, which displays ligand-to-metal
charge transfer transitions in the visible region (Figure 8a). The far UV CD spectrum of Pa-
Bfd, with double minima at 208 and 222 nm, and [θ]222/[θ]208 = R ~ 1.1 (blue in Figure 8b)
is typical of α-helical peptides and consistent with the Bfd fold. In comparison, the spectrum
of apo-Bfd in phosphate buffer shows minima at 222 and 203 nm, with R = 0.45 (black).
The blue shift of the high energy band and decrease in intensity of the 222 nm transition
suggest partial loss of α-helical structure46 upon removal of the [2Fe-2S] cluster. If
phosphate is removed by dialysis against Tris buffer the CD spectrum of apo-Bfd shows
lower [θ]222 and additional blue shift of the high energy transition to 201 nm, with R ~ 0.23
(red), indicating additional loss of structure. Taken together, the observations are in good
agreement with a stabilizing influence of phosphate on the Bfd fold and support the notion
that apo-Bfd is in dynamic equilibrium between an α-helical and a more disordered structure
likely comprised of turns and nascent helices. Assembly of the [2Fe-2S] cluster shifts the
equilibrium toward the α-helical fold revealed by the Pa-Bfd structure.
Iron release from Pa-BfrB was studied as reported before10 by following the time-dependent
formation of [Fe(bipy)3]2+ at 523 nm after addition of excess NADPH to a cuvette
containing the appropriate proteins and excess bipy. Addition of NADPH to a mixture of
BfrB and FPR causes negligible iron release (Δ in Figure 8c), whereas the presence of Pa-
Bfd promotes rapid and complete release of iron from Pa-BfrB (○). In contrast, iron release
in the presence of apo-Bfd is sluggish (□ in Figure 8d), demonstrating that apo-Bfd does not
promote the release of iron from BfrB. These observations suggest that in the previous
study, when apo-Bfd was prepared in situ, iron and sulfide ions may have assembled into a
Bfd-bound iron sulfur cluster, or into non-protein clusters capable of reducing BfrB-iron. In
order to emulate the conditions resulting from preparing apo-Bfd in situ, a cuvette
containing a solution of apo-Bfd, Pa-BfrB and Pa-FPR was treated with 2 equivalents of
Fe2+, 2 equivalents of S2− and excess bipy. Addition of NADPH promoted rapid iron release
from Pa-BfrB (• in Fig. 8d), whereas iron release upon addition of NADPH to a solution of
Pa-BfrB, Pa-FPR, Fe2+ and S2− in the same concentration but lacking apo-Bfd is sluggish
(◆ in Figure 8d). These observations suggest that Fe2+ and S2− can assemble into apo-Bfd
to enable reduction of the ferric core mineral and release of Fe2+ and are consistent with a
previous report showing that a [2Fe-2S] cluster can be assembled into apo-Bfd in the
presence of Fe2+ and S2−.19
Yao et al. Page 8













We have also obtained additional evidence demonstrating the participation of the [2Fe-2S]
cluster by monitoring its oxidation state during the reaction with Pa BfrB in the absence of
reductant (NADPH and FPR): A 30 μM solution of Pa-Bfd in 20 mM phosphate buffer pH
7.6 was placed in a cuvette (black trace in Figure 9a). Treating the Pa-Bfd solution with 0.8
equivalents of sodium dithionite resulted in the nearly featureless UV-vis spectrum
characteristic of a reduced [2Fe-2S] cluster (red trace). The spectrum remained unchanged
for the 15 min it was monitored before a small volume of a solution containing Pa-BfrB
reconstituted with 590 Fe atoms/BfrB and a small volume of EDTA solution were added to
produce a final Pa-BfrB concentration of 0.08 μM and final EDTA concentration of 0.1
mM. The EDTA was added to prevent precipitation of ferrous phosphate, which also causes
protein precipitation and drift of the spectral baseline. The spectral changes brought by the
addition of Pa-BfrB are shown in Figure 9b: The red trace corresponds to reduced Pa-Bfd.
The blue trace, which was obtained 20 s after the addition Pa-BfrB, features a Soret band at
424 nm indicating that the heme in Pa-BfrB is reduced. The magenta, green and black traces
were obtained 1 min, 3 min and 5 min, respectively after the addition of Pa-BfrB; note that
the intensity of peaks characteristic of Pa-Bfd (334 nm and 465 nm) increase and reach their
maximum intensity at ~5 min, with concomitant shift of the Soret band to 418 nm, which
indicates oxidation of the heme in BfrB. To more clearly visualize the oxidation state of the
[2Fe-2S] cluster of Pa-Bfd in the resultant solution, a difference spectrum was obtained by
subtracting a spectrum of 0.08 μM Pa-BfrB from the black trace (5 min) in Figure 9b. The
difference spectrum (red in Figure 9c) is virtually identical to the spectrum obtained from
the solution containing 30 μM oxidized Pa-Bfd (black trace in Figures 9a and 9c). To
correlate these observations to iron release from Pa-BfrB, a similar experiment was
conducted, except that the solution containing reduced Pa-Bfd was made 3 mM in bipy
immediately prior to the addition of Pa-BfrB (no EDTA was needed). This allowed us to
observe the time dependent-formation of Fe2+ detected at 523 nm, in the form of
[Fe(bipy)3]2+ (Figure 9-d). Note that the maximum concentration of [Fe(bipy)3]2+ formed is
~24 μM, a value that is equivalent to the concentration of reduced Pa-Bfd obtained upon
addition of 0.8 equivalents of dithionite to the solution 30 μM in Pa-Bfd. Clearly, these
observations are in good agreement with the notion that the heme in Pa BfrB mediates
electrons between the [2Fe-2S] cluster in Pa Bfd and the iron core in Pa BfrB to promote
release of Fe2+.
Concluding remarks
Although the recovery of Fe2+ from the ferritin cavity requires that electrons traverse the
protein shell and reach the mineral, it is highly unlikely that ferritin-mineral is
indiscriminately reduced in vivo. The delivery of electrons to eukaryotic ferritins from
NADH or NADPH is thought to be carried out by flavin- or xanthine- containing
oxidoreducateses.47 The identity of these enzymes, however, remains unknown. For this
reason, studies directed at probing iron release from ferritin-like molecules have utilized a
wide range of reductants, including dithionite, thiols, ascorbate, diphenols dihydroflavins
and diphenols, to drive the release of iron from ferritin and ferritin-like molecules.7,14,48-51
Although these studies have provided important insights, the significance of molecular
recognition and protein-protein interactions in the control of iron release from ferritin and
ferritin-like molecules has remained mysterious. The identification of bfd genes contiguous
to bfr genes in E. coli11,18 and in P. aeruginosa10,19 and their differential regulation under
conditions of low-iron stress20,21 provided the impetus to demonstrate that Pa-Bfd enables
iron release from Pa-BfrB.10 The manner of Bfd participation in the process, however, was
not clear since Pa-Bfd, or its apo-form prepared in situ, were found to accelerate iron
release. The highly specific Pa-BfrB-Bfd interface reported here strongly supports the notion
that in vivo Pa-Bfd mediates electrons to Pa-BfrB. In addition, experiments with Pa-Bfd and
its apo-form allowed us to unambiguously demonstrate that only Pa-Bfd promotes the
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release of iron from Pa-BfrB. Consequently, the structure of the Pa-BfrB-Bfd complex
enables, for the first time, structural insight into the control exerted by molecular recognition
on the mobilization of iron from a ferritin-like molecule and the electron paths that enable
electrons to traverse the Bfr shell and reduce ferric mineral in the Bfr cavity (Figure 7).
Given that iron storage proteins in bacteria are essential for the survival of pathogens in the
host,15 the insights obtained from the Pa-BfrB-Bfd complex and its function in maintaining
bacterial iron homeostasis, may help in the future development of therapeutic strategies to
treat bacterial infections. In this context, it is important that residues at the Pa-BfrB-Bfd
interface are conserved in Bfr and Bfd sequences from a number of bacteria (Figure 5 and
Figure S1). Moreover, the bfr and bfd genes coding for the Bfrs and Bfds aligned in Figure
S1 are adjacent to one another (Table S1), suggesting that the clustering of the bfd (PA3531)
and bfrB (PA3530) genes in P. aeruginosa is common to a wide number of bacterial species.
Consequently, the specific recognition and binding that is necessary to release iron from
bacterioferritin is likely a mechanism of widespread significance to the understanding of
bacterial iron homeostasis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Structure of Pa BfrB (PDB 3IS7). (a) a subunit dimer and the intersubunit location of heme
which is coordinated by a conserved methionine in each of the subunits, (b) the biological
assembly consisting of 12 subunit-dimers and 12 heme molecules, viewed along a four-fold
pore where a K+ ion (purple sphere) is bound, and (c) a view of the large interior cavity
where the iron mineral is stored, illustrating how heme molecules are buried below the
protein surface with the heme propionates extending into the interior cavity (heme is in
green with O atomos in red, and N atoms in blue).
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Structure of the Pa-BfrB-Bfd complex. (a) The asymmetric unit cell consisting of three BfrB
subunit-dimers, each associated with a Bfd molecule (cyan); Fe-S atoms are represented as
orange and yellow spheres, respectively, the heme molecules between each subunit dimer
are shown in green, potassium atoms in four-fold pores are represented as purple spheres,
and sodium atoms in the B pores as green spheres. (b) Fo-Fc omit map contoured at 3σ
showing the electron density (purple) of Bfd chain G. (c) View of a Bfd molecule (cyan)
bound to the surface of a BfrB subunit-dimer above the heme, which is buried below the
surface. (d) Biological assembly consisting of 12 Bfds bound to 12 BfrB subunit-dimers. (e)
View of a four-fold pore in which K+ (purple) is coordinated by Asn148 and Gln151, (f)
View of a B-pore in which Na+ is coordinated by Asp34, Asp132 and Thr136. The Fo-Fc
omit maps for the K+ and Na+ ions contoured at 3σ are shown in green mesh and
coordinated water molecules as red spheres. (g) Superposition of Pa-BfrB (green) and Pa-
BfrB-Bfd (magenta) structures showing the ferroxidase center ligands.
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The Bfd fold. (a) View of the helix-turn-helix fold of Bfd (chain G) and associated [2Fe-2S]
cluster; Fe and S are shown in orange and yellow spheres, respectively. (b) Zoomed-in view
of the [2Fe-2S] cluster depicting phased anomalous difference maps (green mesh) of the iron
ions obtained from diffraction data collected at λ = 1.73769 Å, contoured at 8σ. (c)
Structural alignment showing how an equivalent of the Bfd structure (cyan) matches a
portion of the structure (magenta) of the α-subunit of PDH1 (PDB: 1Y56); the RMSD of
common Cα atoms in the alignment is 0.34 Å. (d) Structural alignment of Bfd with a portion
of the N’terminal domain of CopZ-NT (PDB: 2HU9); the Zn2+-binding portion has been
omitted to emphasize that the β-hairpin containing Fe ligands C75 and C77 and subsequent
α-helix (magenta) are structurally equivalent to L1 (containing C4 and C6) and α-1 in Pa-
Bfd (cyan). The loop-helix-loop containing C109 and 119 in CopZ-NT (green) is longer and
structurally different from L3 in Pa-Bfd, but the Fe ligand C119 is structurally equivalent to
C41 in Pa-Bfd.
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Phosphate stabilizes the Pa Bfd fold. (a) Main chain average B-factors in Bfd chains G
(magenta), H (green) and I (orange); vertical lines highlight the Cys ligands and the gap in
the green trace is absent electron density in chain H. (b) Fo-Fc omit map contoured at 6σ
(orange mesh) showing the electron density modeled as phosphate coordinated by the side
chains of R26, R29 and K46 in Bfd chain G (cyan); the phosphate is also coordinated, via a
crystal contact, by the side chain of K76 from a nearby BfrB related by the symmetry
operator Y, X, −Z + (001). (c) View of BfrB (gray) and bound Bfd in the asymmetric unit
(spheres) showing the crystal contacts (red spheres) experienced by chain G (magenta), H
(green) and I (orange); the phosphate bound to chain G is shown in blue spheres. The crystal
contacts affecting chains G and H contribute to stabilize short helix α-2 and in the case of
chain G, a specific contact from K76 in a nearby BfrB molecule contributes to organize the
phosphate ion. In chain H which does not experience crystal contacts, helix α-2 and flanking
loops L2 and L3 experience conformational disorder. (d) Plot of per-residue mobility in the
Bfd-phosphate complex (chain G). Residue mobility is a normalized mean square
fluctuation of the residue center of mass calculated by an elastic network model.44 (e) Plot
of the relative change of the mean square fluctuations of Bfd residues upon dissociation of
the Bfd-phosphate complex.
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The Pa-BfrB-Bfd interface. (a & b) Per-residue plot of surface area buried at the complex
interface; contributions from residues in Bfd are shown in cyan and contributions from
residues in the A and B subunits of BfrB are shown in wheat and gray, respectively.
Conserved residues are denoted by (*) and conservative replacements by (:). (c) View of the
complex interface showing Bfd in cyan and subunits A and B of BfrB in wheat and gray,
respectively, oxygen in red, nitrogen in blue, sulfur in yellow and iron in orange. The BfrB
surface was rendered semi-transparent to show the side chains forming the cleft at the dimer
interface. Note the burial of Bfd side chains Y2, L5 and K40 within the cleft, whereas M1
interacts only with subunit A of BfrB via hydrophobic and hydrogen bonding interactions
(dotted lines indicate hydrogen bonding interactions). Iron ligands C6 and C41 also
participate at the complex interface, placing the [2Fe, 2S] cluster of Bfd in close proximity
to the BfrB surface.
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Small rearrangements occur on the surface of Pa-BfrB upon binding Pa-Bfd. (a) Surface
representation of a cleft formed at the subunit-dimer interface in Pa-BfrB (PDB 3IS7) where
Pa-Bfd binds. (b) Binding of Pa-Bfd causes side chain rearrangements in ,  and 
which narrow the cleft to accommodate Y2 and L5 from Pa-Bfd. (c) Cartoon representation
depicting the structural rearrangements in Pa-BfrB brought about by the binding of Pa-Bfd
(cyan). Side chains in unbound Pa-BfrB (green) rearrange to the conformations shown by
the side chains in wheat (subunit A) and gray (subunit B) in the Pa-BfrB-Bfd complex. The
resultant polar and hydrogen bonding interactions at the complex interface are shown by
dashed lines.
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Binding of Pa-Bfd to Pa-BfrB places the iron sulfur cluster of Pa-Bfd in an ideal position to
transfer electrons to the heme in Pa-BfrB. (a) The best path for electron transfer predicted by
the program Harlem is from S2 in Pa-Bfd to heme vinyl carbon CBB in Pa-BfrB, including
two non-bonding jumps and  and  (purple). (b) Inside view of the Pa-BfrB cavity
illustrating the putative path of electron transfer across the Pa-BfrB protein shell, from Pa-
Bfd (cyan) bound at the Pa-BfrB surface to heme buried below the surface (green) through
 and  (purple).
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A [2Fe-2S] cluster in Pa-Bfd is necessary to promote Fe2+ mobilization from Pa-BfrB. (a)
UV-Vis spectra of Pa-Bfd (black) in 50 mM potassium phosphate pH 7.0, 150 mM NaCl, 5
mM DTT, and apo-Bfd (red) in 200 mM potassium phosphate pH 7.0, 5 mM TCEP. (b) Far
UV CD spectra of: (blue) Pa-Bfd in 50 mM potassium phosphate pH 7.0, 4mM NaCl, 0.13
mM DTT showing double minima at 208 and 222 nm; (black) apo-Bfd in 200 mM
potassium phosphate pH 7.0, 1 mM TCEP with a minimum at 203 nm and a shoulder at 222
nm; (red) apo-Bfd in 200 mM Tris, pH 7.0 120 mM NaCl, 1 mM TCEP with a minimum at
201 nm and a shoulder at 223 nm. (c) Time-dependent increase of normalized A523 upon
addition of excess NADPH (final concentration 1.5 mM) to 20 mM phosphate buffer (pH
7.6) containing: (Δ) Pa BfrB (0.25 μM) and Pa FPR (10 μM ), and (○) Pa BfrB (0.25 μM),
Pa-FPR (10 μM) and Pa-Bfd (10 M). (d) Time-dependent increase of normalized A523 upon
addition of excess NADPH to a solution containing: (□) Pa-BfrB (0.25 μM), Pa-FPR (10
μM) and apo-Pa-Bfd (10 μM ); (•) Pa-BfrB (0.25 μM), Pa-FPR (10 μM), apo-Pa-Bfd (10
μM ), (NH4)2Fe(SO4)2 (20 μM) and Na2S (20 μM ); and (◆) Pa-BfrB (0.25 μM), Pa-FPR
(10 μM), (NH4)2Fe(SO4)2 (20 μM) and Na2S (20 μM). A523 was normalized to the
absorbance value expected upon removal of all 600 iron ions in Pa-BfrB.
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(a) (black) UV-Vis spectra of oxidized 30 μM Pa-Bfd in 20 mM potassium phosphate pH
7.6. (red) Spectrum of reduced Pa-Bfd obtained upon addition of 0.8 equivalents of sodium
dithionite relative to oxidized Pa-Bfd. (b) Spectral changes upon addition of Pa-BfrB (0.08
μM final concentration) reconstituted with 590 Fe atoms/BfrB to reduced Pa-Bfd: (red)
spectrum prior to the addition of Pa-BfrB; (blue) 20 s, (magenta) 1 min, (green) 3 min, and
(black) 5 min after the addition of Pa-BfrB. An increase in the intensity at 334 and 465 nm
indicates reoxidation of Pa-Bfd. (c) (red) difference spectrum obtained from subtracting a
spectrum obtained from 0.08 μM Pa-BfrB from the black trace spectrum (5 min) in (b). The
difference spectrum is nearly identical to the spectrum of oxidized 30 μM (black trace). The
addition of EDTA final concentration 0.1 mM immediately prior to the addition of Pa-BfrB
was necessary to prevent formation of insoluble ferrous phosphate, which caused protein
precipitation and drift in the baseline of the spectra. (d) Time-dependent formation of
[Fe(bipy)3]2+ upon addition of excess bipy (3 mM) and Pa-BfrB (0.08 μM) to a solution of
Pa-Bfd reduced as in (a). The maximum concentration of [Fe(bipy)3]2+ formed (normalized
to the initial volume) is ~24 μM and equivalent to the concentration of Pa-Bfd obtained by
reducing 30 μM Pa-Bfd with 0.8 equivalents of dithionite.
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Table 1
Crystallographic data for Pa-BfrB-Bfd refined to 2.0 Å resolution.
BfrB-Bfd
Data Collection
  Unit-cell parameters (Å, °) a=135.81, c=200.89
  Space group P4212
  Resolution (Å)
1 200.89-2.00 (2.03-2.00)
  Wavelength (Å) 1.0000
  Temperature (K) 100
  Observed reflections 1,120,495
  Unique reflections 125,332
  <I/σ(I)>1 15.2 (3.0)
  Completeness (%)
1 100 (100)
  Multiplicity1 8.9 (9.2)
  Rmerge (%)
1, 2 11.7 (80.5)
  Rmeas (%)
1, 4 13.3 (90.3)
  Rpim (%)
1, 4 4.4 (29.6)
Refinement
  Resolution (Å) 47.73-2.0
  Reflections (working/test) 118,964/6,294
  Reflections (working/test) 118,964/6,294
  Rfactor / Rfree (%)
3 15.2/18.3





  Bond lengths (Å) 0.011
  Bond angles (°) 1.185
A verage B factor (Å2)
  All Atoms 24.0
  BfrB/Bfd 20.9/41.4
  Heme/Fe-S/ K+/Na+/phosphate 22.9/26.9/15.3/24.0/35.7
  Water 39.1
  Coordinate error, maximum
  likelihood (Å)
0.22
Ramachandran Plot
  Most favored (%) 99.3
  aAdditionally (%) 0.7
1) Values in parenthesis are for the highest resolution shell.
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2) Rmerge = ΣhklΣi |Ii(hkl) - <I(hkl)>| / ΣhklΣi Ii(hkl), where Ii(hkl) is the intensity measured for the ith reflection and <I(hkl)> is the average
intensity of all reflections with indices hkl.
3) Rfactor = Σhkl ∥Fobs (hkl) | - |Fcalc (hkl) ∥ / Σhkl |Fobs (hkl)|; Rfree is calculated in an identical manner using 5% of randomly selected
reflections that were not included in the refinement.
4) Rmeas = redundancy-independent (multiplicity-weighted) Rmerge52,53. Rpim = precision-indicating (multiplicity-weighted) Rmerge54,55.
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